Member Info for bladesharp

What news are you expecting they have already said no test news till middle of next year?

Thanks Chazzy2 - So reading up on this then no results expected till July 2018

Defo a placing coming now then IMO for the new financial year

As I have mentioned previous the problem we have now is that there is going to be no news on the first test patient for a while and the company is very soon to publish end of year results. I expect there is now very little money in the bank and as I have suggested previously we are due for a placing to generate more funds for the following year and I also suspect they will carry out a consolidation of shares at the same time. Not really much positive news to publish to the market at the moment? Obviously this is just my own opinion of whats going on hence I sold my stake in the company on the spike. I will be following closely and will reinvest at a later date

And now the ask is following amongst the MM's sorry but looks like it is going back down :(

The bid looks like its starting its decent I don't think it will hold out much longer

So with the fact we have now been told that the human trials still haven't started I have started to look further into where we actually are before the end of year results come in. Money in the bank must be getting very low now so in order to get us through another year and also invest in the 2-3 companies a year target Salvarx set we need to get some funds from somewhere. I am now very cautious and have sold out for the time being. This is my own opinion but as always do your own research

The Company notes the recent article in MoneyWeek Magazine about SalvaRx and Intensity Therapeutics Inc., ("Intensity") in which the Company has an 8.5 per cent. interest. The article incorrectly stated that Intensity had dosed its first patient in clinical trials. Intensity expects to dose its first patient shortly at which point a further notification will be made by SalvaRx which will contain full details of the trial including the timeframe for results.

Two days on the trot things are looking up - bring on the news

when was the article dated? any chance u can share the full article?

I had a moan about the lack of any company updates to Jim on twitter and got the response that he liked my tweet.....

I think you mean 4 months

Nice to finally see a little push back north to where this share should currently be. Its been so quiet here for news lately but there is so much potential and we must be so close now to human trials starting. Please bring us some good news soon jim

Wonder if human trials are about to start?

http://www.businesswire.com/news/home/20160602005016/en/Intensity-Therapeutics-Issued-Patent-Immune-based-Cancer-Therapeutic

Good spot JayMonk thanks for the link

Investment in Intensity Therapeutics Inc and Convertible Loan Note SalvaRx (LON: SALV), a biotechnology company focused on immunotherapy for cancer, is today pleased to announce its investment in US-based Intensity Therapeutics Inc. ("Intensity"), a private biotechnology company pioneering a new approach to treating solid tumours. The Company has invested US$2 million in cash for a 9.2% interest in Intensity ("the Investment") as part of a Series A funding round....

Grant funding from the European Commission for a new product SalvaRx (LON: SALV), a biotechnology company focused on immunotherapy for cancer, is pleased to announce that an international multi-disciplinary consortium of 11 academic and commercial partners, including its subsidiary, iOx Therapeutics Ltd. ("iOx"), has received an €8.3 million Horizon 2020 grant to support the development of new immunotherapy candidates. iOx will benefit directly as one of the candidates being developed is a new combination product based on one of its compounds. In addition, iOx will be able to reclaim €150,000 of its development costs associated with the new product......

Shame so quiet here at the moment. I cant wait for the first decent RNS :)

Nothing interesting just that Vela now hold less then 3% following the reverse take over which we already knew